$2.51T
Total marketcap
$61.06B
Total volume
BTC 50.06%     ETH 16.19%
Dominance

Prestige Consumer Healthcare PBH Stock

68.23 USD {{ price }} -1.387482% {{change_pct}}%
Exchange
NYSE
Market Cap
3.39B USD
LOW - HIGH [24H]
68.18 - 68.98 USD
VOLUME [24H]
146.8K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.61 USD

Prestige Consumer Healthcare Price Chart

Prestige Consumer Healthcare PBH Financial and Trading Overview

Prestige Consumer Healthcare stock price 68.23 USD
Previous Close 57.32 USD
Open 57.46 USD
Bid 53.9 USD x 1000
Ask 62.42 USD x 1000
Day's Range 57.11 - 57.92 USD
52 Week Range 48.51 - 67.45 USD
Volume 314.52K USD
Avg. Volume 236.2K USD
Market Cap 2.85B USD
Beta (5Y Monthly) 0.554225
PE Ratio (TTM) N/A
EPS (TTM) -1.61 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date September 27, 2018
1y Target Est 75.25 USD

PBH Valuation Measures

Enterprise Value 4.16B USD
Trailing P/E N/A
Forward P/E 12.287554
PEG Ratio (5 yr expected) 1.69
Price/Sales (ttm) 2.5231311
Price/Book (mrq) 1.9662786
Enterprise Value/Revenue 3.686
Enterprise Value/EBITDA 10.927

Trading Information

Prestige Consumer Healthcare Stock Price History

Beta (5Y Monthly) 0.554225
52-Week Change 4.54%
S&P500 52-Week Change 20.43%
52 Week High 67.45 USD
52 Week Low 48.51 USD
50-Day Moving Average 60.13 USD
200-Day Moving Average 58.94 USD

PBH Share Statistics

Avg. Volume (3 month) 236.2K USD
Avg. Daily Volume (10-Days) 261.61K USD
Shares Outstanding 49.69M
Float 49.36M
Short Ratio 5.61
% Held by Insiders 0.82%
% Held by Institutions 102.62%
Shares Short 1.3M
Short % of Float 3.64%
Short % of Shares Outstanding 2.61%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin -7.29%
Operating Margin (ttm) 30.84%
Gross Margin 56.11%
EBITDA Margin 33.73%

Management Effectiveness

Return on Assets (ttm) 6.18%
Return on Equity (ttm) -5.44%

Income Statement

Revenue (ttm) 1.13B USD
Revenue Per Share (ttm) 22.61 USD
Quarterly Revenue Growth (yoy) 7.09%
Gross Profit (ttm) N/A
EBITDA 380.43M USD
Net Income Avi to Common (ttm) -82306000 USD
Diluted EPS (ttm) -1.63
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 58.49M USD
Total Cash Per Share (mrq) 1.18 USD
Total Debt (mrq) 1.37B USD
Total Debt/Equity (mrq) 94.47 USD
Current Ratio (mrq) 2.438
Book Value Per Share (mrq) 29.121

Cash Flow Statement

Operating Cash Flow (ttm) 229.72M USD
Levered Free Cash Flow (ttm) 165.23M USD

Profile of Prestige Consumer Healthcare

Country United States
State NY
City Tarrytown
Address 660 White Plains Road
ZIP 10591
Phone 914 524 6800
Website https://www.prestigebrands.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 560

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Q&A For Prestige Consumer Healthcare Stock

What is a current PBH stock price?

Prestige Consumer Healthcare PBH stock price today per share is 68.23 USD.

How to purchase Prestige Consumer Healthcare stock?

You can buy PBH shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Prestige Consumer Healthcare?

The stock symbol or ticker of Prestige Consumer Healthcare is PBH.

Which industry does the Prestige Consumer Healthcare company belong to?

The Prestige Consumer Healthcare industry is Drug Manufacturers-Specialty & Generic.

How many shares does Prestige Consumer Healthcare have in circulation?

The max supply of Prestige Consumer Healthcare shares is 49.65M.

What is Prestige Consumer Healthcare Price to Earnings Ratio (PE Ratio)?

Prestige Consumer Healthcare PE Ratio is now.

What was Prestige Consumer Healthcare earnings per share over the trailing 12 months (TTM)?

Prestige Consumer Healthcare EPS is -1.61 USD over the trailing 12 months.

Which sector does the Prestige Consumer Healthcare company belong to?

The Prestige Consumer Healthcare sector is Healthcare.

Prestige Consumer Healthcare PBH included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
Nasdaq US 700 Small Cap Value N NQUS700SCVN 2248.88 USD
-1.58
2241.98 USD 2277.4 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2060.1 USD
-1.99
2051.95 USD 2093.4 USD
NYSE COMPOSITE (DJ) NYA 17639.04 USD
-1.54
Nasdaq US 700 Small Cap Value I NQUS700SCV 2024.5 USD
-1.58
2018.28 USD 2050.17 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1383.38 USD
-2.07
1380.57 USD 1408.57 USD